IGC PHARMA, INC. (IGC) Shareholders’ equity 2016–2025
IGC PHARMA, INC. (IGC) shareholders’ equity at each fiscal year-end, per SEC filings.
$6.3MFY2025 · since FY2016: $13.5M → $6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.3M | -13.5% |
| FY2024 | $7.3M | -50.9% |
| FY2023 | $14.9M | -37.6% |
| FY2022 | $23.9M | -27.2% |
| FY2021 | $32.8M | +23.6% |
| FY2020 | $26.5M | -21.0% |
| FY2019 | $33.6M | +316.3% |
| FY2018 | $8.1M | +9.6% |
| FY2017 | $7.4M | -45.4% |
| FY2016 | $13.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice